Total Net Sales

–10% (from $3,940M in Q3 2024 to $3,550M in Q3 2025)

The 10% decline in total net sales is driven by widespread softness across key markets, with previous robust sales in Q3 2024 now tapering off amid subdued consumer demand. The decline is especially evident in the EMEA region (–17.5%) and has also affected the Americas (–6%), suggesting that regional challenges and a less favorable retail environment are impacting overall performance. " " " " " "

Operating Income

–42% (from $531M in Q3 2024 to $306M in Q3 2025)

The 42% decrease in operating income is a consequence of lower revenue combined with a widened cost base. The current period's lower margins, compared to Q3 2024, indicate that cost pressure and possible higher expense items (such as restructuring or impairment charges carried from previous strategic initiatives) are significantly eroding profitability. " "

Net Earnings & EPS

–52% (net earnings: from $335M to $159M; EPS from $0.92 to $0.44)

A 52% drop in net earnings and diluted EPS results from the compounded effect of the operating income decline, higher effective taxes, and non-recurring charges. The current period reflects the negative impacts of prior period cost structures and additional burdens that were less marked in Q3 2024, thereby intensifying the decline in profitability metrics. " " "

Geographic Revenue – Americas

–6% (from $1,117M to $1,052M)

The Americas experienced a modest decline (–6%) due to a combination of retail softness and changes in revenue mix compared to the previous period, where incremental gains (such as from strategic acquisitions or pricing actions) had previously buoyed performance. The current period's lower sales signal emerging challenges in this market. " " " "

Geographic Revenue – EMEA

–17.5% (from $1,647M to $1,358M)

The EMEA region saw a significant drop of 17.5% as previous period gains were offset by persistent challenges like declining travel retail activity and softer consumer sentiment. This considerable decline suggests that the regional retail environment has deteriorated markedly compared to Q3 2024. " " " "

Geographic Revenue – Asia/Pacific

Marginal decline (from $1,176M to $1,140M)

Sales in Asia/Pacific were relatively stable, with only a marginal decrease. This contrasts with more pronounced declines in other regions, highlighting that while the region faced challenges similar to Mainland China and travel retail, effective commercial activations in certain markets helped mitigate deeper losses observed in the Americas and EMEA. " " " "

Operating Cash Flow

–47% (from $534M in Q3 2024 to $284M in Q3 2025)

Operational cash flow fell by nearly 47%, reflecting the lower earnings and less favorable working capital changes compared to Q3 2024. While last year’s period benefited from significant inventory reductions that bolstered cash flow, the current period saw smaller improvements in working capital, compounded by lower overall profitability. " "

Organic Net Sales

Q3 2025

Decrease 10%–8%; currency impact –2 percentage points "

N/A

no current guidance

Adjusted EPS

Q3 2025

$0.20–$0.30 range; currency dilution of $0.04 "

N/A

no current guidance

Gross Margin

Q3 2025

Moderate expansion expected "

N/A

no current guidance

Effective Tax Rate

Q3 2025

Approximately 36% (compared to 30.5% prior year) "

N/A

no current guidance

Global Travel Retail Business

Q3 2025

Strong double-digit sales decline expected "

N/A

no current guidance

Market Share Recovery

Q2 2025 saw mixed signals with subdued consumer sentiment in China affecting growth and modest stabilization in the U.S.. " " Q4 2024 focused on stabilizing U.S. market share with cautious progress in a competitive environment. "

Q3 2025 reports robust market share gains in the U.S. (e.g., Clinique’s 11-month streak, The Ordinary’s move to #2 in skincare), gains across all four categories in China, and strong performance in Japan. " "

Consistent improvement with a renewed positive momentum as recovery efforts now yield tangible share gains compared to earlier stabilization challenges.

Operational Transformation & Margin Improvement Initiatives

In Q2 2025, the PRGP demonstrated significant progress with margin expansions and restructuring measures " " , while Q4 2024 emphasized cost reductions, streamlined processes, and expense leverage actions. " "

Q3 2025 highlights concrete cost savings via a 30% reduction in executive expenses, clear workforce trimming (2,600 net positions, 20% middle management cut), and a quarterly 300-basis point gross margin expansion. " "

Continued progress with deeper tangible cost reductions and margin improvements as initiatives mature from strategic plans to measurable operational outcomes.

Persistent Travel Retail & Inventory Challenges

Q2 2025 noted weak Asia travel retail trends and challenges with elevated inventories impacting sales. " " Q4 2024 detailed steep declines in key markets like Hainan and higher-than-desired inventory levels. " "

Q3 2025 continues to stress persistent issues with a 28% organic decline in travel retail and focused efforts on stabilizing reduced inventory levels, even as retailer tightening in North America is factored into the outlook. " "

A persistent challenge where travel retail remains a consistent headwind, with both periods echoing ongoing issues despite strategic mitigations.

Tariff Mitigation & Supply Chain Diversification

No coverage was provided in Q2 2025 or Q4 2024 on these strategies.

Q3 2025 introduces detailed strategies including regionalized manufacturing, reducing China-sourced products to below 10%, and a task force that has already cut tariff impact by over 40%. " " "

A new topic introduced in Q3 2025, highlighting emerging focus on mitigating external tariff pressures and diversifying the supply chain.

Consumer Sentiment in Key Markets

Q2 2025 discussed subdued sentiment in China and Korea negatively impacting sales, while Q4 2024 noted tentative sentiment in Mainland China coupled with inflationary pressures in North America and weakness in Asia travel retail. " " "

Q3 2025 continues to report weak consumer sentiment in the U.S., China, and Korea—impacting inventory management and overall performance—indicating that consumer caution remains a key issue. " " "

A consistent headwind with persistent negative sentiment across regions, underscoring its ongoing influence on strategic and operational plans.

Accelerated Innovation & Increased Product Launches

Q2 2025 emphasized a strategic vision to triple innovation speed with tailored, rapidly launched products using AI integration, while Q4 2024 highlighted targeted skin care innovations and precision marketing tools like a trend AI tool to activate market trends. " " " " "

Q3 2025 expands on the innovation agenda with multiple new product launches (e.g., Moisture Surge Active Booster, Double Wear Concealer, new MAC lip shades) and further AI-driven marketing efforts for enhanced consumer engagement. "

Acceleration continues with stronger AI integration and a broader portfolio, marking a qualitative leap in speed and innovation breadth compared to earlier periods.

Restructuring & Workforce Reductions

Q2 2025 reported an ambitious global restructuring (targeting 5,800-7,000 net reductions) with significant expected charges, while Q4 2024 focused on cost efficiency actions, including restructuring charges of $100–$120 million and streamlining processes. " " "

Q3 2025 offers more concrete progress with a 2,600 net position cut, a 20% reduction in middle management, and a 30% reduction in executive expenses, underscoring ongoing actions under the PRGP. " "

Ongoing restructuring with a shift from ambitious projections to demonstrable progress, focusing on operational efficiency and targeted workforce streamlining.

Competitive Dynamics in North America & Moderation in Prestige Growth

Q2 2025 described flat net sales and competitive pressures in North America with challenges from slow channels, and Q4 2024 described an intensely competitive environment, especially in brick‐and‐mortar channels, with moderate U.S. growth. " " " "

Q3 2025 does not provide explicit commentary on this topic, indicating less emphasis or a shift in focus compared to earlier discussions.

Diminished explicit coverage in the current period suggesting the company may be prioritizing market share recovery narratives over detailed competitive dynamics analysis.

Leadership Transition Risks (CEO Retirement)

Q4 2024 saw extensive discussion of CEO Fabrizio Freda’s planned retirement, detailed succession planning, and risk mitigation measures. " " Q2 2025 did not mention this topic.

Q3 2025 does not mention any leadership transition risks, indicating that the issue has been resolved or is no longer a focal concern.

No longer mentioned in the current period, suggesting that transition risks have been addressed and leadership concerns have receded from the immediate strategic agenda.